91 related articles for article (PubMed ID: 608516)
1. Chemo-immunotherapy of mouse tumours using cyclophosphamide and C. parvum.
Scott MT
Dev Biol Stand; 1977 Apr 13-15; 38():307-10. PubMed ID: 608516
[TBL] [Abstract][Full Text] [Related]
2. A role for T lymphocytes in the antitumour action of systemic C. parvum.
McBride WH; Peters LJ; Mason KA; Milas L
Dev Biol Stand; 1977 Apr 13-15; 38():253-7. PubMed ID: 305374
[TBL] [Abstract][Full Text] [Related]
3. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
4. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
Bomford R
Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
[TBL] [Abstract][Full Text] [Related]
5. Possible mechanisms in the anti-tumour activity of C. parvum.
Cullen RT
Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
[TBL] [Abstract][Full Text] [Related]
6. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
Urano M; Yamashita T; Suit HD; Gerweck LE
Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
[TBL] [Abstract][Full Text] [Related]
8. First impressions of I.V. C. parvum in patients with solid tumours.
Günther U; Hoefer-Janker H; Scheef W
Dev Biol Stand; 1977 Apr 13-15; 38():507-8. PubMed ID: 608543
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses, antitumour antibodies and Ig class and subclass levels in C. parvum treated mice.
James K
Dev Biol Stand; 1977 Apr 13-15; 38():173-81. PubMed ID: 608503
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the antitumour activities of glucans and C. parvum.
Bomford R; Moreno C
Dev Biol Stand; 1977 Apr 13-15; 38():291-5. PubMed ID: 608513
[TBL] [Abstract][Full Text] [Related]
11. Conditions favouring the selection of either specific or non specific C. parvum-mediated, systemic antitumour immunity in mice.
Scott MT
Dev Biol Stand; 1977 Apr 13-15; 38():273-6. PubMed ID: 415921
[TBL] [Abstract][Full Text] [Related]
12. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
13. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
Vanhaelen CP; Fisher RI
Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
[TBL] [Abstract][Full Text] [Related]
14. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
15. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
[TBL] [Abstract][Full Text] [Related]
17. The effect of pretreatment with Corynebacterium parvum on the growth of a chemical induced transplanted murine tumor.
Borberg H; Sauerland D; Jaeckel I
Dev Biol Stand; 1977 Apr 13-15; 38():323-7. PubMed ID: 608519
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.
Currie GA
Br Med J; 1970 Feb; 1(5695):541-4. PubMed ID: 5435189
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum.
McBride WH; Howie S
Clin Exp Immunol; 1984 Jul; 57(1):139-48. PubMed ID: 6235074
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
